Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 1.08 M1.55 M1.52 M2.29 M1.35 M1.58 M 6.74 M Research & development —————— — Operating income -871 K-695 K-862 K-1.55 M-723 K-816 K -3.95 M Non-Operating Income, Total 203 K1.24 M912 K972 K826 K980 K 3.69 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 203 K1.24 M912 K972 K826 K980 K 3.69 M Unusual income/expense —————— — Pretax income -668 K545 K50 K-580 K103 K164 K -263 K Equity in earnings —————— — Taxes -32 K00-32 K00 -32 K Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -636 K545 K50 K-612 K103 K164 K -295 K Discontinued operations -17 K6 000102 K-7 000-8 000-9 000 78 K Net income -653 K551 K152 K-619 K95 K155 K -217 K Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -653 K551 K152 K-619 K95 K155 K -217 K Basic earnings per share (Basic EPS) -0.060.050.01-0.050.010.01 -0.02 Diluted earnings per share (Diluted EPS) -0.060.050.01-0.050.010.01 -0.02 Average basic shares outstanding 11.55 M11.57 M11.57 M11.57 M11.57 K11.57 M — Diluted shares outstanding 11.55 M11.57 M11.57 M11.57 M11.64 K11.64 M — EBITDA -783 K-607 K-830 K-1.79 M-629 K-721 K -3.97 M EBIT -871 K-695 K-862 K-1.96 M-723 K-816 K -4.36 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 88 K88 K32 K176 K94 K95 K 397 K